These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 11083512)

  • 1. CD95-mediated apoptosis and DNA fragmentation in MS.
    Heesen C; Georghiu S; Gbadamosi J; Schoser BG
    Acta Neurol Scand; 2000 Nov; 102(5):333-6. PubMed ID: 11083512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis induction in Jurkat cells and sCD95 levels in women's sera are related with the risk of developing cervical cancer.
    Aguilar-Lemarroy A; Romero-Ramos JE; Olimon-Andalon V; Hernandez-Flores G; Lerma-Diaz JM; Ortiz-Lazareno PC; Morgan-Villela G; Del Toro-Arreola S; Bravo-Cuellar A; Jave-Suarez LF
    BMC Cancer; 2008 Apr; 8():99. PubMed ID: 18405371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atorvastatin does not alter serum levels of sCD95 and sCD95L in multiple sclerosis.
    Sellner J; Greeve I; Findling O; Grandgirard D; Leib SL; Mattle HP
    Clin Exp Immunol; 2008 May; 152(2):280-4. PubMed ID: 18341614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of soluble CD95 are not associated with amelioration of multiple sclerosis during pregnancy.
    Ehrlich S; Haas J; Zipp F; Infante-Duarte C
    J Neurol Sci; 2007 Jan; 252(1):83-7. PubMed ID: 17169375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble CD95 concentrations are increased in patients with severe systemic lupus erythematosus, but not in their first degree relatives.
    van der Linden MW; van Lopik T; Aarden LA; Westendorp RG; Huizinga TW
    Ann Rheum Dis; 2001 Mar; 60(3):237-41. PubMed ID: 11171685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble forms of CD95 and CD95 ligand after living related liver transplantation.
    Seino K; Kayagaki N; Yamaguchi N; Takada Y; Uyama S; Kiuchi T; Tanaka K; Yagita H; Okumura K; Fukao K
    Transplantation; 1999 Feb; 67(4):634-6. PubMed ID: 10071041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fas expression on T cells and sFas in relapsing-remitting multiple sclerosis.
    Bilinska M; Frydecka I; Podemski R; Gruszka E
    Acta Neurol Scand; 2003 Jun; 107(6):387-93. PubMed ID: 12757469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum CD95 of relapsing remitting multiple sclerosis patients protects from CD95-mediated apoptosis.
    Zipp F; Otzelberger K; Dichgans J; Martin R; Weller M
    J Neuroimmunol; 1998 Jun; 86(2):151-4. PubMed ID: 9663560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary lesions and serum levels of soluble Fas (sCD95) in former hard coal miners.
    Hoffmeyer F; Henry J; Borowitzki G; Merget R; Bünger J; Brüning T; Raulf-Heimsoth M
    Eur J Med Res; 2010 Nov; 15 Suppl 2(Suppl 2):60-3. PubMed ID: 21147622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Axonal damage induced by cerebrospinal fluid from patients with relapsing-remitting multiple sclerosis.
    Alcázar A; Regidor I; Masjuan J; Salinas M; Alvarez-Cermeño JC
    J Neuroimmunol; 2000 Apr; 104(1):58-67. PubMed ID: 10683515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble CD95 in the serum of patients with low and intermediate grade malignant lymphomas: absence of prognostic correlations.
    Munker R; Younes A; Cabanillas F; Andreeff M
    Leuk Lymphoma; 1997 Nov; 27(5-6):517-21. PubMed ID: 9477134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CSF levels of soluble HLA-G and Fas molecules are inversely associated to MRI evidence of disease activity in patients with relapsing-remitting multiple sclerosis.
    Fainardi E; Rizzo R; Melchiorri L; Stignani M; Castellazzi M; Tamborino C; Paolino E; Tola MR; Granieri E; Baricordi OR
    Mult Scler; 2008 May; 14(4):446-54. PubMed ID: 18208868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The levels of soluble CD95 antigen and CD95+ mononuclear cells in patients with chronic obstructive lung diseases].
    Kubysheva NI; Postnikova LB; Presniakova NB; Novikov VV
    Klin Lab Diagn; 2009 Mar; (3):22-3. PubMed ID: 19391241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased serum concentrations of soluble CD95/Fas and caspase 1/ICE in patients with acute angina.
    Ankersmit HJ; Weber T; Auer J; Roth G; Brunner M; Kvas E; Moser B; Spreitzer S; Lassnig E; Maurer E; Hartl P; Wolner E; Boltz-Nitulescu G; Eber B
    Heart; 2004 Feb; 90(2):151-4. PubMed ID: 14729783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of apoptosis-related proteins, p53, and DNA fragmentation in sarcomas of the pulmonary artery.
    Gaumann A; Tews DS; Mayer E; Dahm M; Petrow PK; Otto M; Kirkpatrick CJ; Kriegsmann J
    Cancer; 2001 Sep; 92(5):1237-44. PubMed ID: 11571738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired Fas-independent apoptosis of T lymphocytes in patients with multiple sclerosis.
    Sharief MK
    J Neuroimmunol; 2000 Sep; 109(2):236-43. PubMed ID: 10996226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune and Epstein-Barr virus gene expression in cerebrospinal fluid and peripheral blood mononuclear cells from patients with relapsing-remitting multiple sclerosis.
    Veroni C; Marnetto F; Granieri L; Bertolotto A; Ballerini C; Repice AM; Schirru L; Coghe G; Cocco E; Anastasiadou E; Puopolo M; Aloisi F
    J Neuroinflammation; 2015 Jul; 12():132. PubMed ID: 26169064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble Fas/FasLare elevated in the serum and cerebrospinal fluid of patients with neurocysticercosis.
    Chen X; Yu X; Wang Y; Zhu J; Gu J
    Parasitol Res; 2017 Nov; 116(11):3027-3036. PubMed ID: 28965226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA 26a Expression in Peripheral Blood Mononuclear Cells and Correlation with Serum Interleukin-17 in Relapsing-Remitting Multiple Sclerosis Patients.
    Mahmoud FM; ElSheshtawy NM; Zaki WK; Zamzam DM; Fahim NM
    Egypt J Immunol; 2017 Jun; 24(2):71-82. PubMed ID: 29528581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers of inflammation and axonal degeneration/damage in patients with newly diagnosed multiple sclerosis: contributions of the soluble CD163 CSF/serum ratio to a biomarker panel.
    Stilund M; Gjelstrup MC; Petersen T; Møller HJ; Rasmussen PV; Christensen T
    PLoS One; 2015; 10(4):e0119681. PubMed ID: 25860354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.